Table 2.
Multiplicative interaction | Additive interaction | |||||
---|---|---|---|---|---|---|
CRARs | APOE ε4 non‐carrier | APOE ε4 carrier | HR (95% CI) † ; P | RERI (95% CI) † | AP (95% CI) † | SI (95% CI) † |
L5 | ||||||
Quarter 1–3 | 1.00 [Reference] | 3.43 (2.78, 4.25); <0.001 | 1.32 (0.90, 1.93); 0.161 | 1.48 (0.27, 2.69) | 0.29 (0.10, 0.49) | 1.58 (1.11, 2.26) |
Quarter 4 | 1.11 (0.84, 1.48); 0.467 | 5.03 (3.88, 6.51); <0.001 | ||||
M10 | ||||||
>50 | 1.00 [Reference] | 4.32 (2.86, 6.54); <0.001 | 0.84 (0.53, 1.33); 0.467 | 1.59 (0.05, 3.13) | 0.23 (0.02, 0.45) | 1.38 (0.98, 1.95) |
≤50 | 1.85 (1.31, 2.63); <0.001 | 6.77 (4.79, 9.57); <0.001 | ||||
Relative amplitude | ||||||
Quarter 2–4 | 1.00 [Reference] | 4.12 (3.26, 5.22); <0.001 | 0.80 (0.56, 1.15); 0.231 | 1.86 (0.25, 3.46) | 0.26 (0.08, 0.44) | 1.43 (1.07, 1.92) |
Quarter 1 | 2.15 (1.65, 2.80); <0.001 | 7.13 (5.46, 9.31); <0.001 | ||||
L5 onset | ||||||
Intermediate to delayed | 1.00 [Reference] | 3.84 (3.14, 4.68); <0.001 | 0.87 (0.57, 1.35); 0.539 | 0.19 (−1.13, 1.50) | 0.04 (−0.25, 0.34) | 1.06 (0.71, 1.59) |
Advanced | 1.29 (0.94, 1.76); 0.116 | 4.31 (3.19, 5.83); <0.001 |
Abbreviations: AP, attributable proportion due to interaction; APOE, apolipoprotein E; CI, confidence interval; CRAR, circadian rest‐activity rhythm; HR, hazard ratio; L5, the least active 5‐h period; M10, the most active 10‐h period; RERI, relative excess risk due to interaction; SI, the synergy index.
Multivariable Cox model was adjusted for age, sex, education level, ethnicity, Townsend index of deprivation, recruitment center, season of accelerometer wear, smoking status, alcohol intake, healthy diet score, obesity, history of diabetes, hypertension, depression, and APOE ε4 carrier.